Maximilian von Eynatten

Maximilian von Eynatten is a seasoned professional in the field of clinical science and development, currently serving as Head of Global Clinical Science at Aimmune Therapeutics since October 2020 and as Head of Global Clinical Development at Nestlé Health Science since July 2019. Prior experience includes a decade at Boehringer Ingelheim, where Maximilian held the position of Global Head of Medical Affairs in the area of Cardio-Metabolism from June 2009 to June 2019. Additionally, Maximilian contributed to academia as a Faculty and Clinical Researcher in the Department of Medicine at Technical University Munich from October 2006 to May 2009.